<html><head><style>body{font-family:"Times New Roman", Times, serif}.Bold{font-weight:bolder}.font-size\:9px{font-size:9px}.font-size\:11px{font-size:11px}.Heading1,.Heading.\31 {font-size:32px}.Heading2,.Heading.\32,.Subpart{font-size:24px}.Heading3,.Heading.\33 {font-size:20.8px}.Heading4,.Heading.\34 {font-size:16px}ol,li,ul{list-style:none}.SmallCaps{font-variant:small-caps}.data-about{padding-top:10px}p{margin:0;padding:7px}br{display:none}.rangeWrapperHighlight{background-color:#add2ff}.caseWrapperHighlight{background-color:#6fd33d}.whyWrapperHighlight{background-color:#fc5151}.revWrapperHighlight{background-color:#add2ff;padding:1px}.Ctr,.Subpart{text-align:center}img.Right{float:right}.Right{text-align:right}.List1{margin-left:0px;text-indent:0}.List2{margin-left:0.25in;text-indent:0}.List3{margin-left:0.5in;text-indent:0}.List4{margin-left:0.75in;text-indent:0}.List5{margin-left:1in;text-indent:0}.List6{margin-left:1.25in;text-indent:0}.List7{margin-left:1.5in;text-indent:0}.List8{margin-left:1.75in;text-indent:0}.List9{margin-left:2in;text-indent:0}.italic{font-style:italic}.regnavigation{display:none}.Yellow{background-color:yellow}.LightBlue{background-color:#4863a0}.AquaGreen{background-color:#03bb85}.section{background-color:#eeeeee;border:1px solid #cccccc;padding:5px 10px}
</style><head><div xmlns:TCE="http://www.TCE.com" xmlns:TCEext="http://www.TCE.com/xslt-extensions" xmlns:ditaarch="http://dita.oasis-open.org/architecture/2005/" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xs="http://www.w3.org/2001/XMLSchema" class="l4 NMCARS"><p>**ID__NMCARS_5225.70033__ID** </p><div TCE:source="concept" TCE:Parent="" TCE:id="NMCARS_5225.70033" class="NMCARS_5225.70033 "><h4 TCE:Parent="concept" TCE:outputclass="Heading 4" class="Heading 4 "><span TCE:source="ph" TCE:Parent="title" TCE:props="autonumber" class="autonumber ">5225.7003-3</span> Exceptions.</h4><div TCE:source="conbody" TCE:Parent="concept"><p TCE:source="p" TCE:Parent="conbody" TCE:id="PfJKTL" TCE:outputclass="Normal" class="PfJKTL Normal ">(b)(2)(ii) Report on all contracts (including task orders/delivery orders) for the acquisition of COTS end items valued at $5 million or more per item purchased during the preceding fiscal year. In addition to the requirements at PGI 225.7003-3(b)(2)(B), include the contract line item number (CLIN), quantity, and unit price for each excepted COTS end item reported. Submit the required annual report not later than October 15th to DASN(P) by email at <a TCE:source="xref" TCE:Parent="p" TCE:href="mailto:Rdaj&amp;as.fct@navy.mil" TCE:format="mailto" href="mailto:Rdaj&amp;as.fct@navy.mil" TCE:scope="external"><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">RDAJ&amp;As.fct</span><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">@navy.mil</span></a> with the subject “[Activity Name] DFARS 225-7003-3 - Annual COTS End Items Report (Fiscal year).”</p><p TCE:source="p" TCE:Parent="conbody" TCE:id="hyAKet" TCE:outputclass="Normal" class="hyAKet Normal ">(b)(5) Using the format in Annex 3, submit required DNADs for approval by:</p><p TCE:source="p" TCE:Parent="conbody" TCE:id="uKqXEP" TCE:outputclass="List2" class="uKqXEP List2 ">(i) SECNAV via DASN(P) by email at <a TCE:source="xref" TCE:Parent="p" TCE:href="mailto:RDAJ&amp;As.fct@navy.mil" TCE:format="mailto" href="mailto:RDAJ&amp;As.fct@navy.mil" TCE:scope="external"><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">RDAJ&amp;As.fct@navy.mil</span></a> with the subject “[Activity</p><p TCE:source="p" TCE:Parent="conbody" TCE:id="ElaIwx" TCE:outputclass="List2" class="ElaIwx List2 ">Name] DFARS 225.7003-3 – DNAD Approval by SECNAV.” When submitting DNADs for approval, include analysis of market research and analysis of alternatives memorandum as supporting documentation.</p><p TCE:source="p" TCE:Parent="conbody" TCE:id="rHtOot" TCE:outputclass="List2" class="rHtOot List2 ">(ii) USD(A&amp;S) with a courtesy copy to DASN(P) by email at <a TCE:source="xref" TCE:Parent="p" TCE:href="mailto:RDAJ&amp;As.fct@navy.mil" TCE:format="mailto" href="mailto:RDAJ&amp;As.fct@navy.mil" TCE:scope="external"><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">RDAJ&amp;As.fct@navy.mil</span></a> with the subject “[Activity Name] DFARS 225.7003-3 - DNAD Approval by USD(A&amp;S).”</p><p TCE:source="p" TCE:Parent="conbody" TCE:id="lsdRao" TCE:outputclass="Normal" class="lsdRao Normal ">(c)(2) Submit required commercial derivative military article determinations for approval by SECNAV via DASN(P) by email at <a TCE:source="xref" TCE:Parent="p" TCE:href="mailto:Rdaj&amp;as.fct@navy.mil" TCE:format="mailto" href="mailto:Rdaj&amp;as.fct@navy.mil" TCE:scope="external"><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">RDAJ&amp;As.fct</span><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">@navy.mil</span></a> with the subject “[Activity Name] DFARS 225.7003-3 – Determination Approval by SECNAV.”</p><p TCE:source="p" TCE:Parent="conbody" TCE:id="ladAUs" TCE:outputclass="Normal" class="ladAUs Normal ">(d) When submitting the request for national security interest determination to USD(A&amp;S) for approval, provide a courtesy copy to DASN(P) by email at <a TCE:source="xref" TCE:Parent="p" TCE:href="mailto:Rdaj&amp;as.fct@navy.mil" TCE:format="mailto" href="mailto:Rdaj&amp;as.fct@navy.mil" TCE:scope="external"><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">RDAJ&amp;As.fct</span><span style="text-decoration:underline; " TCE:source="u" TCE:Parent="xref">@navy.mil</span></a> with the subject “[Activity Name] DFARS 225.7003-3 – CC: Determination Approval by USD(A&amp;S).”</p></div></div></div></html>